Steven E. Nissen, Stephen J. Nicholls and Kathy Wolski respond to a letter to the editor about their article "Comparison of Pioglitazone vs. Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Trial" in a previous issue.